Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM
Clinical trial NCT04588220 · UNKNOWN
Trial details
- NCT number
- NCT04588220
- Sponsor
- Cengiz Gokcek Women's and Children's Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-07
- Primary completion
- 2021-10-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.